Global Antiviral Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
Region:Global
Product Code:MR64248
November 2021
119
About the Report
Based on the Antiviral Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Antiviral Drugs market covered in Chapter 5:
Gilead Sciences
AbbVie
Novartis
Merck
Bristol-Myers Squibb
GlaxoSmithKline
Roche
Johnson & Johnson
In Chapter 6, on the basis of types, the Antiviral Drugs market from 2015 to 2025 is primarily split into:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
In Chapter 7, on the basis of applications, the Antiviral Drugs market from 2015 to 2025 covers:
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Scope of the Report
Products
Table of Contents
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Antiviral Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Gilead Sciences
5.1.1 Gilead Sciences Company Profile
5.1.2 Gilead Sciences Business Overview
5.1.3 Gilead Sciences Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Gilead Sciences Antiviral Drugs Products Introduction
5.2 AbbVie
5.2.1 AbbVie Company Profile
5.2.2 AbbVie Business Overview
5.2.3 AbbVie Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 AbbVie Antiviral Drugs Products Introduction
5.3 Novartis
5.3.1 Novartis Company Profile
5.3.2 Novartis Business Overview
5.3.3 Novartis Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Novartis Antiviral Drugs Products Introduction
5.4 Merck
5.4.1 Merck Company Profile
5.4.2 Merck Business Overview
5.4.3 Merck Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Merck Antiviral Drugs Products Introduction
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Company Profile
5.5.2 Bristol-Myers Squibb Business Overview
5.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Bristol-Myers Squibb Antiviral Drugs Products Introduction
5.6 GlaxoSmithKline
5.6.1 GlaxoSmithKline Company Profile
5.6.2 GlaxoSmithKline Business Overview
5.6.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 GlaxoSmithKline Antiviral Drugs Products Introduction
5.7 Roche
5.7.1 Roche Company Profile
5.7.2 Roche Business Overview
5.7.3 Roche Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Roche Antiviral Drugs Products Introduction
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Company Profile
5.8.2 Johnson & Johnson Business Overview
5.8.3 Johnson & Johnson Antiviral Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Johnson & Johnson Antiviral Drugs Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Antiviral Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Antiviral Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Antiviral Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Antiviral Drugs Price by Types (2015-2020)
6.2 Global Antiviral Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Antiviral Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Antiviral Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Antiviral Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Antiviral Drugs Sales, Price and Growth Rate of Reverse Transcriptase Inhibitors
6.3.2 Global Antiviral Drugs Sales, Price and Growth Rate of Protease Inhibitors
6.3.3 Global Antiviral Drugs Sales, Price and Growth Rate of Fusion Inhibitors
6.3.4 Global Antiviral Drugs Sales, Price and Growth Rate of Immune System Modulators
6.4 Global Antiviral Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Reverse Transcriptase Inhibitors Market Revenue and Sales Forecast (2020-2025)
6.4.2 Protease Inhibitors Market Revenue and Sales Forecast (2020-2025)
6.4.3 Fusion Inhibitors Market Revenue and Sales Forecast (2020-2025)
6.4.4 Immune System Modulators Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Antiviral Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Antiviral Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Antiviral Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Antiviral Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Antiviral Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Antiviral Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Antiviral Drugs Revenue, Sales and Growth Rate of Hepatitis Therapeutics (2015-2020)
7.3.2 Global Antiviral Drugs Revenue, Sales and Growth Rate of HIV/AIDS Therapeutics (2015-2020)
7.3.3 Global Antiviral Drugs Revenue, Sales and Growth Rate of Herpes Therapeutics (2015-2020)
7.3.4 Global Antiviral Drugs Revenue, Sales and Growth Rate of Influenza Therapeutics (2015-2020)
7.4 Global Antiviral Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hepatitis Therapeutics Market Revenue and Sales Forecast (2020-2025)
7.4.2 HIV/AIDS Therapeutics Market Revenue and Sales Forecast (2020-2025)
7.4.3 Herpes Therapeutics Market Revenue and Sales Forecast (2020-2025)
7.4.4 Influenza Therapeutics Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Antiviral Drugs Sales by Regions (2015-2020)
8.2 Global Antiviral Drugs Market Revenue by Regions (2015-2020)
8.3 Global Antiviral Drugs Market Forecast by Regions (2020-2025)
9 North America Antiviral Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Antiviral Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Antiviral Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Antiviral Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Antiviral Drugs Market Analysis by Country
9.6.1 U.S. Antiviral Drugs Sales and Growth Rate
9.6.2 Canada Antiviral Drugs Sales and Growth Rate
9.6.3 Mexico Antiviral Drugs Sales and Growth Rate
10 Europe Antiviral Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Antiviral Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Antiviral Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Antiviral Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Antiviral Drugs Market Analysis by Country
10.6.1 Germany Antiviral Drugs Sales and Growth Rate
10.6.2 United Kingdom Antiviral Drugs Sales and Growth Rate
10.6.3 France Antiviral Drugs Sales and Growth Rate
10.6.4 Italy Antiviral Drugs Sales and Growth Rate
10.6.5 Spain Antiviral Drugs Sales and Growth Rate
10.6.6 Russia Antiviral Drugs Sales and Growth Rate
11 Asia-Pacific Antiviral Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Antiviral Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Antiviral Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Antiviral Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Antiviral Drugs Market Analysis by Country
11.6.1 China Antiviral Drugs Sales and Growth Rate
11.6.2 Japan Antiviral Drugs Sales and Growth Rate
11.6.3 South Korea Antiviral Drugs Sales and Growth Rate
11.6.4 Australia Antiviral Drugs Sales and Growth Rate
11.6.5 India Antiviral Drugs Sales and Growth Rate
12 South America Antiviral Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Antiviral Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Antiviral Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Antiviral Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Antiviral Drugs Market Analysis by Country
12.6.1 Brazil Antiviral Drugs Sales and Growth Rate
12.6.2 Argentina Antiviral Drugs Sales and Growth Rate
12.6.3 Columbia Antiviral Drugs Sales and Growth Rate
13 Middle East and Africa Antiviral Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Antiviral Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Antiviral Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Antiviral Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Antiviral Drugs Market Analysis by Country
13.6.1 UAE Antiviral Drugs Sales and Growth Rate
13.6.2 Egypt Antiviral Drugs Sales and Growth Rate
13.6.3 South Africa Antiviral Drugs Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
Research Methodology
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.